Oppenheimer Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.54M Sell
23,347
-14,229
-38% -$2.16M 0.04% 403
2025
Q1
$5.66M Buy
37,576
+4,671
+14% +$703K 0.07% 290
2024
Q4
$6.07M Sell
32,905
-13,651
-29% -$2.52M 0.07% 284
2024
Q3
$9.17M Sell
46,556
-989
-2% -$195K 0.11% 207
2024
Q2
$9.82M Buy
47,545
+4,231
+10% +$874K 0.13% 191
2024
Q1
$11.7M Sell
43,314
-1,034
-2% -$280K 0.17% 147
2023
Q4
$10.5M Sell
44,348
-3,690
-8% -$872K 0.15% 172
2023
Q3
$9.41M Sell
48,038
-752
-2% -$147K 0.14% 171
2023
Q2
$10.3M Buy
48,790
+1,896
+4% +$399K 0.15% 169
2023
Q1
$9.46M Buy
46,894
+5,041
+12% +$1.02M 0.15% 170
2022
Q4
$9.12M Sell
41,853
-229
-0.5% -$49.9K 0.15% 178
2022
Q3
$8.28M Buy
42,082
+6,447
+18% +$1.27M 0.15% 174
2022
Q2
$7.63M Sell
35,635
-383
-1% -$82K 0.13% 195
2022
Q1
$10.2M Buy
36,018
+8,367
+30% +$2.38M 0.15% 171
2021
Q4
$10.4M Buy
27,651
+1,386
+5% +$522K 0.14% 179
2021
Q3
$10.8M Sell
26,265
-2,098
-7% -$866K 0.15% 155
2021
Q2
$10.5M Buy
28,363
+565
+2% +$209K 0.15% 164
2021
Q1
$8.06M Buy
27,798
+11,190
+67% +$3.24M 0.12% 194
2020
Q4
$4.15M Sell
16,608
-475
-3% -$119K 0.07% 310
2020
Q3
$3.87M Sell
17,083
-3,704
-18% -$839K 0.08% 295
2020
Q2
$3.62M Buy
20,787
+2,047
+11% +$357K 0.07% 288
2020
Q1
$2.37M Sell
18,740
-61
-0.3% -$7.7K 0.06% 315
2019
Q4
$2.87M Buy
18,801
+274
+1% +$41.9K 0.06% 327
2019
Q3
$2.45M Sell
18,527
-8
-0% -$1.06K 0.05% 355
2019
Q2
$2.63M Buy
18,535
+1,218
+7% +$173K 0.06% 339
2019
Q1
$2.52M Sell
17,317
-396
-2% -$57.5K 0.06% 345
2018
Q4
$2.01M Buy
17,713
+9
+0.1% +$1.02K 0.05% 367
2018
Q3
$2.38M Sell
17,704
-195
-1% -$26.2K 0.05% 371
2018
Q2
$2.01M Sell
17,899
-3,002
-14% -$337K 0.05% 398
2018
Q1
$2.23M Buy
20,901
+1,741
+9% +$186K 0.06% 355
2017
Q4
$2.07M Hold
19,160
0.05% 368
2017
Q3
$2.07M Buy
19,160
+9,415
+97% +$1.02M 0.05% 370
2017
Q2
$985K Buy
9,745
+4,804
+97% +$486K 0.03% 587
2017
Q1
$444K Buy
+4,941
New +$444K 0.01% 817